nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—CA4—Alzheimer's disease	0.611	1	CbGaD
Furosemide—SLC22A8—choroid plexus—Alzheimer's disease	0.0135	0.236	CbGeAlD
Furosemide—Indapamide—CA4—Alzheimer's disease	0.00263	0.485	CrCbGaD
Furosemide—Bumetanide—CA4—Alzheimer's disease	0.00231	0.426	CrCbGaD
Furosemide—CA14—telencephalon—Alzheimer's disease	0.00182	0.0318	CbGeAlD
Furosemide—SLC12A1—forebrain—Alzheimer's disease	0.00178	0.0311	CbGeAlD
Furosemide—SLC12A1—telencephalon—Alzheimer's disease	0.00163	0.0286	CbGeAlD
Furosemide—CA12—forebrain—Alzheimer's disease	0.00154	0.027	CbGeAlD
Furosemide—PGD—forebrain—Alzheimer's disease	0.00146	0.0256	CbGeAlD
Furosemide—CA12—telencephalon—Alzheimer's disease	0.00142	0.0248	CbGeAlD
Furosemide—PGD—telencephalon—Alzheimer's disease	0.00134	0.0235	CbGeAlD
Furosemide—CA1—forebrain—Alzheimer's disease	0.00122	0.0214	CbGeAlD
Furosemide—CA7—cerebellum—Alzheimer's disease	0.00121	0.0212	CbGeAlD
Furosemide—CA1—telencephalon—Alzheimer's disease	0.00112	0.0197	CbGeAlD
Furosemide—CA9—cerebellum—Alzheimer's disease	0.00107	0.0186	CbGeAlD
Furosemide—CA14—cerebellum—Alzheimer's disease	0.00101	0.0177	CbGeAlD
Furosemide—CA7—brain—Alzheimer's disease	0.000986	0.0172	CbGeAlD
Furosemide—SLC12A1—nervous system—Alzheimer's disease	0.000965	0.0169	CbGeAlD
Furosemide—CA4—forebrain—Alzheimer's disease	0.000956	0.0167	CbGeAlD
Furosemide—SLC12A1—central nervous system—Alzheimer's disease	0.000929	0.0162	CbGeAlD
Furosemide—CA2—embryo—Alzheimer's disease	0.000896	0.0157	CbGeAlD
Furosemide—SLCO2A1—nervous system—Alzheimer's disease	0.00089	0.0156	CbGeAlD
Furosemide—CA4—telencephalon—Alzheimer's disease	0.000879	0.0154	CbGeAlD
Furosemide—SLCO2A1—central nervous system—Alzheimer's disease	0.000857	0.015	CbGeAlD
Furosemide—CA12—nervous system—Alzheimer's disease	0.000838	0.0147	CbGeAlD
Furosemide—CA14—brain—Alzheimer's disease	0.000821	0.0144	CbGeAlD
Furosemide—Pollakiuria—Galantamine—Alzheimer's disease	0.000819	0.00405	CcSEcCtD
Furosemide—Thrombophlebitis—Rivastigmine—Alzheimer's disease	0.000816	0.00403	CcSEcCtD
Furosemide—Diabetes mellitus—Rivastigmine—Alzheimer's disease	0.000812	0.00401	CcSEcCtD
Furosemide—Vascular purpura—Memantine—Alzheimer's disease	0.000807	0.00399	CcSEcCtD
Furosemide—Deafness—Memantine—Alzheimer's disease	0.000807	0.00399	CcSEcCtD
Furosemide—CA12—central nervous system—Alzheimer's disease	0.000807	0.0141	CbGeAlD
Furosemide—Polyuria—Rivastigmine—Alzheimer's disease	0.000804	0.00397	CcSEcCtD
Furosemide—Hyperglycaemia—Galantamine—Alzheimer's disease	0.0008	0.00395	CcSEcCtD
Furosemide—Hyponatraemia—Donepezil—Alzheimer's disease	0.000798	0.00394	CcSEcCtD
Furosemide—PGD—nervous system—Alzheimer's disease	0.000794	0.0139	CbGeAlD
Furosemide—CA2—forebrain—Alzheimer's disease	0.000793	0.0139	CbGeAlD
Furosemide—Deafness—Rivastigmine—Alzheimer's disease	0.00079	0.0039	CcSEcCtD
Furosemide—Vascular purpura—Rivastigmine—Alzheimer's disease	0.00079	0.0039	CcSEcCtD
Furosemide—Renal failure—Galantamine—Alzheimer's disease	0.000777	0.00384	CcSEcCtD
Furosemide—PGD—central nervous system—Alzheimer's disease	0.000764	0.0134	CbGeAlD
Furosemide—Irritability—Donepezil—Alzheimer's disease	0.000759	0.00375	CcSEcCtD
Furosemide—Urinary retention—Donepezil—Alzheimer's disease	0.000756	0.00373	CcSEcCtD
Furosemide—Dermatitis bullous—Memantine—Alzheimer's disease	0.000755	0.00373	CcSEcCtD
Furosemide—CA5B—nervous system—Alzheimer's disease	0.000752	0.0131	CbGeAlD
Furosemide—Purpura—Memantine—Alzheimer's disease	0.000749	0.0037	CcSEcCtD
Furosemide—Hepatobiliary disease—Galantamine—Alzheimer's disease	0.000748	0.00369	CcSEcCtD
Furosemide—PGD—cerebellum—Alzheimer's disease	0.000747	0.0131	CbGeAlD
Furosemide—Blood creatinine increased—Donepezil—Alzheimer's disease	0.000745	0.00368	CcSEcCtD
Furosemide—Thirst—Rivastigmine—Alzheimer's disease	0.000742	0.00367	CcSEcCtD
Furosemide—Dehydration—Donepezil—Alzheimer's disease	0.00074	0.00365	CcSEcCtD
Furosemide—Dermatitis bullous—Rivastigmine—Alzheimer's disease	0.000739	0.00365	CcSEcCtD
Furosemide—SLC12A1—brain—Alzheimer's disease	0.000737	0.0129	CbGeAlD
Furosemide—Lethargy—Memantine—Alzheimer's disease	0.000737	0.00364	CcSEcCtD
Furosemide—Purpura—Rivastigmine—Alzheimer's disease	0.000733	0.00362	CcSEcCtD
Furosemide—CA2—telencephalon—Alzheimer's disease	0.000729	0.0127	CbGeAlD
Furosemide—Orthostatic hypotension—Donepezil—Alzheimer's disease	0.000726	0.00359	CcSEcCtD
Furosemide—Hyponatraemia—Memantine—Alzheimer's disease	0.000725	0.00358	CcSEcCtD
Furosemide—CA5B—central nervous system—Alzheimer's disease	0.000724	0.0127	CbGeAlD
Furosemide—Hypokalaemia—Donepezil—Alzheimer's disease	0.000724	0.00357	CcSEcCtD
Furosemide—Cramp muscle—Donepezil—Alzheimer's disease	0.000716	0.00354	CcSEcCtD
Furosemide—SLC22A6—brain—Alzheimer's disease	0.000715	0.0125	CbGeAlD
Furosemide—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.000709	0.0035	CcSEcCtD
Furosemide—Muscular weakness—Donepezil—Alzheimer's disease	0.000701	0.00346	CcSEcCtD
Furosemide—Urinary tract disorder—Galantamine—Alzheimer's disease	0.000701	0.00346	CcSEcCtD
Furosemide—Urethral disorder—Galantamine—Alzheimer's disease	0.000696	0.00344	CcSEcCtD
Furosemide—Abdominal distension—Donepezil—Alzheimer's disease	0.000692	0.00342	CcSEcCtD
Furosemide—Irritability—Memantine—Alzheimer's disease	0.000689	0.0034	CcSEcCtD
Furosemide—Urinary retention—Memantine—Alzheimer's disease	0.000687	0.00339	CcSEcCtD
Furosemide—Visual impairment—Galantamine—Alzheimer's disease	0.000684	0.00338	CcSEcCtD
Furosemide—SLCO2A1—brain—Alzheimer's disease	0.000681	0.0119	CbGeAlD
Furosemide—Eosinophilia—Donepezil—Alzheimer's disease	0.000681	0.00336	CcSEcCtD
Furosemide—Blood creatinine increased—Memantine—Alzheimer's disease	0.000676	0.00334	CcSEcCtD
Furosemide—Pancreatitis—Donepezil—Alzheimer's disease	0.000674	0.00333	CcSEcCtD
Furosemide—Urinary retention—Rivastigmine—Alzheimer's disease	0.000672	0.00332	CcSEcCtD
Furosemide—Dehydration—Memantine—Alzheimer's disease	0.000671	0.00332	CcSEcCtD
Furosemide—CA1—nervous system—Alzheimer's disease	0.000664	0.0116	CbGeAlD
Furosemide—Eye disorder—Galantamine—Alzheimer's disease	0.000663	0.00328	CcSEcCtD
Furosemide—Tinnitus—Galantamine—Alzheimer's disease	0.000662	0.00327	CcSEcCtD
Furosemide—Orthostatic hypotension—Memantine—Alzheimer's disease	0.000659	0.00326	CcSEcCtD
Furosemide—Hypokalaemia—Memantine—Alzheimer's disease	0.000657	0.00324	CcSEcCtD
Furosemide—Dehydration—Rivastigmine—Alzheimer's disease	0.000657	0.00324	CcSEcCtD
Furosemide—Orthostatic hypotension—Rivastigmine—Alzheimer's disease	0.000645	0.00319	CcSEcCtD
Furosemide—Angiopathy—Galantamine—Alzheimer's disease	0.000644	0.00318	CcSEcCtD
Furosemide—Hypokalaemia—Rivastigmine—Alzheimer's disease	0.000643	0.00317	CcSEcCtD
Furosemide—Immune system disorder—Galantamine—Alzheimer's disease	0.000641	0.00317	CcSEcCtD
Furosemide—CA12—brain—Alzheimer's disease	0.000641	0.0112	CbGeAlD
Furosemide—CA1—central nervous system—Alzheimer's disease	0.000639	0.0112	CbGeAlD
Furosemide—Muscular weakness—Memantine—Alzheimer's disease	0.000637	0.00314	CcSEcCtD
Furosemide—Cramp muscle—Rivastigmine—Alzheimer's disease	0.000636	0.00314	CcSEcCtD
Furosemide—Pollakiuria—Donepezil—Alzheimer's disease	0.000635	0.00314	CcSEcCtD
Furosemide—Arrhythmia—Galantamine—Alzheimer's disease	0.000634	0.00313	CcSEcCtD
Furosemide—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000623	0.00308	CcSEcCtD
Furosemide—Hyperglycaemia—Donepezil—Alzheimer's disease	0.00062	0.00306	CcSEcCtD
Furosemide—Malnutrition—Galantamine—Alzheimer's disease	0.000618	0.00305	CcSEcCtD
Furosemide—Pancreatitis—Memantine—Alzheimer's disease	0.000612	0.00302	CcSEcCtD
Furosemide—Flatulence—Galantamine—Alzheimer's disease	0.000609	0.00301	CcSEcCtD
Furosemide—PGD—brain—Alzheimer's disease	0.000607	0.0106	CbGeAlD
Furosemide—Dysgeusia—Galantamine—Alzheimer's disease	0.000605	0.00299	CcSEcCtD
Furosemide—Renal failure—Donepezil—Alzheimer's disease	0.000602	0.00297	CcSEcCtD
Furosemide—Pancreatitis—Rivastigmine—Alzheimer's disease	0.000599	0.00296	CcSEcCtD
Furosemide—Muscle spasms—Galantamine—Alzheimer's disease	0.000594	0.00293	CcSEcCtD
Furosemide—Sweating—Donepezil—Alzheimer's disease	0.000588	0.0029	CcSEcCtD
Furosemide—Vision blurred—Galantamine—Alzheimer's disease	0.000582	0.00288	CcSEcCtD
Furosemide—Pollakiuria—Memantine—Alzheimer's disease	0.000576	0.00285	CcSEcCtD
Furosemide—CA5B—brain—Alzheimer's disease	0.000575	0.01	CbGeAlD
Furosemide—Anaemia—Galantamine—Alzheimer's disease	0.000571	0.00282	CcSEcCtD
Furosemide—Agitation—Galantamine—Alzheimer's disease	0.000568	0.0028	CcSEcCtD
Furosemide—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000564	0.00278	CcSEcCtD
Furosemide—Hyperglycaemia—Memantine—Alzheimer's disease	0.000563	0.00278	CcSEcCtD
Furosemide—SLC22A8—nervous system—Alzheimer's disease	0.00056	0.00979	CbGeAlD
Furosemide—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000557	0.00275	CcSEcCtD
Furosemide—Vertigo—Galantamine—Alzheimer's disease	0.000555	0.00274	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000552	0.00272	CcSEcCtD
Furosemide—Hyperglycaemia—Rivastigmine—Alzheimer's disease	0.000551	0.00272	CcSEcCtD
Furosemide—Renal failure—Memantine—Alzheimer's disease	0.000547	0.0027	CcSEcCtD
Furosemide—Drowsiness—Rivastigmine—Alzheimer's disease	0.000544	0.00269	CcSEcCtD
Furosemide—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000543	0.00268	CcSEcCtD
Furosemide—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.00054	0.00266	CcSEcCtD
Furosemide—Urethral disorder—Donepezil—Alzheimer's disease	0.000539	0.00266	CcSEcCtD
Furosemide—SLC22A8—central nervous system—Alzheimer's disease	0.000539	0.00943	CbGeAlD
Furosemide—Renal failure—Rivastigmine—Alzheimer's disease	0.000535	0.00264	CcSEcCtD
Furosemide—Visual impairment—Donepezil—Alzheimer's disease	0.00053	0.00262	CcSEcCtD
Furosemide—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000526	0.0026	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000522	0.00258	CcSEcCtD
Furosemide—Sweating—Rivastigmine—Alzheimer's disease	0.000522	0.00258	CcSEcCtD
Furosemide—Agranulocytosis—Memantine—Alzheimer's disease	0.000519	0.00256	CcSEcCtD
Furosemide—CA4—nervous system—Alzheimer's disease	0.000519	0.00907	CbGeAlD
Furosemide—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000515	0.00254	CcSEcCtD
Furosemide—Dry mouth—Galantamine—Alzheimer's disease	0.000515	0.00254	CcSEcCtD
Furosemide—Tinnitus—Donepezil—Alzheimer's disease	0.000513	0.00253	CcSEcCtD
Furosemide—Confusional state—Galantamine—Alzheimer's disease	0.000509	0.00251	CcSEcCtD
Furosemide—CA1—brain—Alzheimer's disease	0.000507	0.00887	CbGeAlD
Furosemide—CA4—central nervous system—Alzheimer's disease	0.0005	0.00874	CbGeAlD
Furosemide—Shock—Galantamine—Alzheimer's disease	0.000496	0.00245	CcSEcCtD
Furosemide—Nervous system disorder—Galantamine—Alzheimer's disease	0.000495	0.00244	CcSEcCtD
Furosemide—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000494	0.00244	CcSEcCtD
Furosemide—Urinary tract disorder—Memantine—Alzheimer's disease	0.000493	0.00244	CcSEcCtD
Furosemide—Arrhythmia—Donepezil—Alzheimer's disease	0.000491	0.00243	CcSEcCtD
Furosemide—Skin disorder—Galantamine—Alzheimer's disease	0.00049	0.00242	CcSEcCtD
Furosemide—Urethral disorder—Memantine—Alzheimer's disease	0.00049	0.00242	CcSEcCtD
Furosemide—CA4—cerebellum—Alzheimer's disease	0.000488	0.00854	CbGeAlD
Furosemide—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000488	0.00241	CcSEcCtD
Furosemide—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000483	0.00238	CcSEcCtD
Furosemide—Visual impairment—Memantine—Alzheimer's disease	0.000481	0.00238	CcSEcCtD
Furosemide—Bumetanide—PTGS2—Alzheimer's disease	0.000481	0.0889	CrCbGaD
Furosemide—Anorexia—Galantamine—Alzheimer's disease	0.000481	0.00237	CcSEcCtD
Furosemide—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000479	0.00237	CcSEcCtD
Furosemide—Malnutrition—Donepezil—Alzheimer's disease	0.000479	0.00236	CcSEcCtD
Furosemide—Erythema—Donepezil—Alzheimer's disease	0.000479	0.00236	CcSEcCtD
Furosemide—Erythema multiforme—Memantine—Alzheimer's disease	0.000472	0.00233	CcSEcCtD
Furosemide—Flatulence—Donepezil—Alzheimer's disease	0.000472	0.00233	CcSEcCtD
Furosemide—Hypotension—Galantamine—Alzheimer's disease	0.000471	0.00233	CcSEcCtD
Furosemide—Visual impairment—Rivastigmine—Alzheimer's disease	0.000471	0.00233	CcSEcCtD
Furosemide—Dysgeusia—Donepezil—Alzheimer's disease	0.000469	0.00232	CcSEcCtD
Furosemide—Eye disorder—Memantine—Alzheimer's disease	0.000467	0.00231	CcSEcCtD
Furosemide—Tinnitus—Memantine—Alzheimer's disease	0.000466	0.0023	CcSEcCtD
Furosemide—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000462	0.00228	CcSEcCtD
Furosemide—Muscle spasms—Donepezil—Alzheimer's disease	0.00046	0.00227	CcSEcCtD
Furosemide—Eye disorder—Rivastigmine—Alzheimer's disease	0.000457	0.00226	CcSEcCtD
Furosemide—Tinnitus—Rivastigmine—Alzheimer's disease	0.000456	0.00225	CcSEcCtD
Furosemide—Angiopathy—Memantine—Alzheimer's disease	0.000453	0.00224	CcSEcCtD
Furosemide—Paraesthesia—Galantamine—Alzheimer's disease	0.000453	0.00224	CcSEcCtD
Furosemide—Vision blurred—Donepezil—Alzheimer's disease	0.000451	0.00223	CcSEcCtD
Furosemide—Immune system disorder—Memantine—Alzheimer's disease	0.000451	0.00223	CcSEcCtD
Furosemide—Somnolence—Galantamine—Alzheimer's disease	0.000448	0.00221	CcSEcCtD
Furosemide—Arrhythmia—Memantine—Alzheimer's disease	0.000446	0.0022	CcSEcCtD
Furosemide—ALB—brain—Alzheimer's disease	0.000446	0.00779	CbGeAlD
Furosemide—Angiopathy—Rivastigmine—Alzheimer's disease	0.000443	0.00219	CcSEcCtD
Furosemide—Anaemia—Donepezil—Alzheimer's disease	0.000443	0.00219	CcSEcCtD
Furosemide—Agitation—Donepezil—Alzheimer's disease	0.00044	0.00217	CcSEcCtD
Furosemide—Decreased appetite—Galantamine—Alzheimer's disease	0.000438	0.00216	CcSEcCtD
Furosemide—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000437	0.00216	CcSEcCtD
Furosemide—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000435	0.00215	CcSEcCtD
Furosemide—Malnutrition—Memantine—Alzheimer's disease	0.000435	0.00215	CcSEcCtD
Furosemide—Fatigue—Galantamine—Alzheimer's disease	0.000435	0.00215	CcSEcCtD
Furosemide—Constipation—Galantamine—Alzheimer's disease	0.000431	0.00213	CcSEcCtD
Furosemide—CA2—nervous system—Alzheimer's disease	0.00043	0.00752	CbGeAlD
Furosemide—Vertigo—Donepezil—Alzheimer's disease	0.00043	0.00212	CcSEcCtD
Furosemide—Flatulence—Memantine—Alzheimer's disease	0.000428	0.00212	CcSEcCtD
Furosemide—SLC22A8—brain—Alzheimer's disease	0.000428	0.00749	CbGeAlD
Furosemide—Dysgeusia—Memantine—Alzheimer's disease	0.000426	0.0021	CcSEcCtD
Furosemide—Erythema—Rivastigmine—Alzheimer's disease	0.000425	0.0021	CcSEcCtD
Furosemide—Malnutrition—Rivastigmine—Alzheimer's disease	0.000425	0.0021	CcSEcCtD
Furosemide—Flatulence—Rivastigmine—Alzheimer's disease	0.000419	0.00207	CcSEcCtD
Furosemide—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000417	0.00206	CcSEcCtD
Furosemide—Feeling abnormal—Galantamine—Alzheimer's disease	0.000416	0.00205	CcSEcCtD
Furosemide—CA2—central nervous system—Alzheimer's disease	0.000414	0.00724	CbGeAlD
Furosemide—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000412	0.00204	CcSEcCtD
Furosemide—Vision blurred—Memantine—Alzheimer's disease	0.00041	0.00202	CcSEcCtD
Furosemide—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000409	0.00202	CcSEcCtD
Furosemide—CA2—cerebellum—Alzheimer's disease	0.000405	0.00708	CbGeAlD
Furosemide—Anaemia—Memantine—Alzheimer's disease	0.000402	0.00198	CcSEcCtD
Furosemide—Vision blurred—Rivastigmine—Alzheimer's disease	0.000401	0.00198	CcSEcCtD
Furosemide—Agitation—Memantine—Alzheimer's disease	0.0004	0.00197	CcSEcCtD
Furosemide—Dry mouth—Donepezil—Alzheimer's disease	0.000399	0.00197	CcSEcCtD
Furosemide—Abdominal pain—Galantamine—Alzheimer's disease	0.000399	0.00197	CcSEcCtD
Furosemide—Body temperature increased—Galantamine—Alzheimer's disease	0.000399	0.00197	CcSEcCtD
Furosemide—SLC22A5—cerebellum—Alzheimer's disease	0.000398	0.00697	CbGeAlD
Furosemide—CA4—brain—Alzheimer's disease	0.000397	0.00694	CbGeAlD
Furosemide—Confusional state—Donepezil—Alzheimer's disease	0.000394	0.00195	CcSEcCtD
Furosemide—Anaemia—Rivastigmine—Alzheimer's disease	0.000393	0.00194	CcSEcCtD
Furosemide—Agitation—Rivastigmine—Alzheimer's disease	0.000391	0.00193	CcSEcCtD
Furosemide—Vertigo—Memantine—Alzheimer's disease	0.000391	0.00193	CcSEcCtD
Furosemide—Leukopenia—Memantine—Alzheimer's disease	0.000389	0.00192	CcSEcCtD
Furosemide—Shock—Donepezil—Alzheimer's disease	0.000385	0.0019	CcSEcCtD
Furosemide—Nervous system disorder—Donepezil—Alzheimer's disease	0.000383	0.00189	CcSEcCtD
Furosemide—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000383	0.00189	CcSEcCtD
Furosemide—Vertigo—Rivastigmine—Alzheimer's disease	0.000382	0.00189	CcSEcCtD
Furosemide—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000378	0.00187	CcSEcCtD
Furosemide—Anorexia—Donepezil—Alzheimer's disease	0.000373	0.00184	CcSEcCtD
Furosemide—Hypersensitivity—Galantamine—Alzheimer's disease	0.000372	0.00183	CcSEcCtD
Furosemide—Hypotension—Donepezil—Alzheimer's disease	0.000365	0.0018	CcSEcCtD
Furosemide—Dry mouth—Memantine—Alzheimer's disease	0.000362	0.00179	CcSEcCtD
Furosemide—Asthenia—Galantamine—Alzheimer's disease	0.000362	0.00179	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00036	0.00178	CcSEcCtD
Furosemide—Confusional state—Memantine—Alzheimer's disease	0.000358	0.00177	CcSEcCtD
Furosemide—Dry mouth—Rivastigmine—Alzheimer's disease	0.000354	0.00175	CcSEcCtD
Furosemide—Paraesthesia—Donepezil—Alzheimer's disease	0.000351	0.00173	CcSEcCtD
Furosemide—Confusional state—Rivastigmine—Alzheimer's disease	0.00035	0.00173	CcSEcCtD
Furosemide—Shock—Memantine—Alzheimer's disease	0.000349	0.00172	CcSEcCtD
Furosemide—Nervous system disorder—Memantine—Alzheimer's disease	0.000348	0.00172	CcSEcCtD
Furosemide—Somnolence—Donepezil—Alzheimer's disease	0.000347	0.00172	CcSEcCtD
Furosemide—Thrombocytopenia—Memantine—Alzheimer's disease	0.000347	0.00172	CcSEcCtD
Furosemide—Diarrhoea—Galantamine—Alzheimer's disease	0.000345	0.0017	CcSEcCtD
Furosemide—Skin disorder—Memantine—Alzheimer's disease	0.000345	0.0017	CcSEcCtD
Furosemide—Hyperhidrosis—Memantine—Alzheimer's disease	0.000343	0.00169	CcSEcCtD
Furosemide—Shock—Rivastigmine—Alzheimer's disease	0.000342	0.00169	CcSEcCtD
Furosemide—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00034	0.00168	CcSEcCtD
Furosemide—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00034	0.00168	CcSEcCtD
Furosemide—Decreased appetite—Donepezil—Alzheimer's disease	0.00034	0.00168	CcSEcCtD
Furosemide—Anorexia—Memantine—Alzheimer's disease	0.000338	0.00167	CcSEcCtD
Furosemide—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000337	0.00167	CcSEcCtD
Furosemide—Skin disorder—Rivastigmine—Alzheimer's disease	0.000337	0.00167	CcSEcCtD
Furosemide—Fatigue—Donepezil—Alzheimer's disease	0.000337	0.00166	CcSEcCtD
Furosemide—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000336	0.00166	CcSEcCtD
Furosemide—Constipation—Donepezil—Alzheimer's disease	0.000334	0.00165	CcSEcCtD
Furosemide—Pain—Donepezil—Alzheimer's disease	0.000334	0.00165	CcSEcCtD
Furosemide—Dizziness—Galantamine—Alzheimer's disease	0.000333	0.00165	CcSEcCtD
Furosemide—Hypotension—Memantine—Alzheimer's disease	0.000332	0.00164	CcSEcCtD
Furosemide—Anorexia—Rivastigmine—Alzheimer's disease	0.000331	0.00163	CcSEcCtD
Furosemide—CA2—brain—Alzheimer's disease	0.000329	0.00575	CbGeAlD
Furosemide—Hypotension—Rivastigmine—Alzheimer's disease	0.000324	0.0016	CcSEcCtD
Furosemide—SLC22A5—brain—Alzheimer's disease	0.000324	0.00566	CbGeAlD
Furosemide—Feeling abnormal—Donepezil—Alzheimer's disease	0.000322	0.00159	CcSEcCtD
Furosemide—Vomiting—Galantamine—Alzheimer's disease	0.000321	0.00158	CcSEcCtD
Furosemide—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00032	0.00158	CcSEcCtD
Furosemide—Paraesthesia—Memantine—Alzheimer's disease	0.000319	0.00157	CcSEcCtD
Furosemide—Rash—Galantamine—Alzheimer's disease	0.000318	0.00157	CcSEcCtD
Furosemide—Dermatitis—Galantamine—Alzheimer's disease	0.000318	0.00157	CcSEcCtD
Furosemide—Headache—Galantamine—Alzheimer's disease	0.000316	0.00156	CcSEcCtD
Furosemide—Somnolence—Memantine—Alzheimer's disease	0.000315	0.00156	CcSEcCtD
Furosemide—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000312	0.00154	CcSEcCtD
Furosemide—Urticaria—Donepezil—Alzheimer's disease	0.00031	0.00153	CcSEcCtD
Furosemide—Body temperature increased—Donepezil—Alzheimer's disease	0.000309	0.00153	CcSEcCtD
Furosemide—Abdominal pain—Donepezil—Alzheimer's disease	0.000309	0.00153	CcSEcCtD
Furosemide—Somnolence—Rivastigmine—Alzheimer's disease	0.000309	0.00152	CcSEcCtD
Furosemide—Decreased appetite—Memantine—Alzheimer's disease	0.000308	0.00152	CcSEcCtD
Furosemide—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000306	0.00151	CcSEcCtD
Furosemide—Fatigue—Memantine—Alzheimer's disease	0.000306	0.00151	CcSEcCtD
Furosemide—Constipation—Memantine—Alzheimer's disease	0.000303	0.0015	CcSEcCtD
Furosemide—Pain—Memantine—Alzheimer's disease	0.000303	0.0015	CcSEcCtD
Furosemide—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000302	0.00149	CcSEcCtD
Furosemide—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.0003	0.00148	CcSEcCtD
Furosemide—Nausea—Galantamine—Alzheimer's disease	0.0003	0.00148	CcSEcCtD
Furosemide—Fatigue—Rivastigmine—Alzheimer's disease	0.000299	0.00148	CcSEcCtD
Furosemide—Pain—Rivastigmine—Alzheimer's disease	0.000297	0.00147	CcSEcCtD
Furosemide—Constipation—Rivastigmine—Alzheimer's disease	0.000297	0.00147	CcSEcCtD
Furosemide—Feeling abnormal—Memantine—Alzheimer's disease	0.000292	0.00144	CcSEcCtD
Furosemide—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00029	0.00143	CcSEcCtD
Furosemide—Hypersensitivity—Donepezil—Alzheimer's disease	0.000288	0.00142	CcSEcCtD
Furosemide—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000286	0.00141	CcSEcCtD
Furosemide—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000284	0.0014	CcSEcCtD
Furosemide—Urticaria—Memantine—Alzheimer's disease	0.000282	0.00139	CcSEcCtD
Furosemide—Abdominal pain—Memantine—Alzheimer's disease	0.000281	0.00139	CcSEcCtD
Furosemide—Body temperature increased—Memantine—Alzheimer's disease	0.000281	0.00139	CcSEcCtD
Furosemide—Asthenia—Donepezil—Alzheimer's disease	0.00028	0.00138	CcSEcCtD
Furosemide—Pruritus—Donepezil—Alzheimer's disease	0.000277	0.00137	CcSEcCtD
Furosemide—Urticaria—Rivastigmine—Alzheimer's disease	0.000276	0.00136	CcSEcCtD
Furosemide—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000274	0.00136	CcSEcCtD
Furosemide—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000274	0.00136	CcSEcCtD
Furosemide—Diarrhoea—Donepezil—Alzheimer's disease	0.000267	0.00132	CcSEcCtD
Furosemide—Hypersensitivity—Memantine—Alzheimer's disease	0.000261	0.00129	CcSEcCtD
Furosemide—Dizziness—Donepezil—Alzheimer's disease	0.000258	0.00128	CcSEcCtD
Furosemide—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000256	0.00126	CcSEcCtD
Furosemide—Asthenia—Memantine—Alzheimer's disease	0.000255	0.00126	CcSEcCtD
Furosemide—Pruritus—Memantine—Alzheimer's disease	0.000251	0.00124	CcSEcCtD
Furosemide—Asthenia—Rivastigmine—Alzheimer's disease	0.000249	0.00123	CcSEcCtD
Furosemide—Vomiting—Donepezil—Alzheimer's disease	0.000249	0.00123	CcSEcCtD
Furosemide—Rash—Donepezil—Alzheimer's disease	0.000246	0.00122	CcSEcCtD
Furosemide—Dermatitis—Donepezil—Alzheimer's disease	0.000246	0.00122	CcSEcCtD
Furosemide—Pruritus—Rivastigmine—Alzheimer's disease	0.000246	0.00121	CcSEcCtD
Furosemide—Headache—Donepezil—Alzheimer's disease	0.000245	0.00121	CcSEcCtD
Furosemide—Diarrhoea—Memantine—Alzheimer's disease	0.000243	0.0012	CcSEcCtD
Furosemide—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000238	0.00117	CcSEcCtD
Furosemide—Dizziness—Memantine—Alzheimer's disease	0.000235	0.00116	CcSEcCtD
Furosemide—Nausea—Donepezil—Alzheimer's disease	0.000232	0.00115	CcSEcCtD
Furosemide—Dizziness—Rivastigmine—Alzheimer's disease	0.00023	0.00113	CcSEcCtD
Furosemide—Vomiting—Memantine—Alzheimer's disease	0.000226	0.00111	CcSEcCtD
Furosemide—Rash—Memantine—Alzheimer's disease	0.000224	0.0011	CcSEcCtD
Furosemide—Dermatitis—Memantine—Alzheimer's disease	0.000224	0.0011	CcSEcCtD
Furosemide—Headache—Memantine—Alzheimer's disease	0.000222	0.0011	CcSEcCtD
Furosemide—Vomiting—Rivastigmine—Alzheimer's disease	0.000221	0.00109	CcSEcCtD
Furosemide—Rash—Rivastigmine—Alzheimer's disease	0.000219	0.00108	CcSEcCtD
Furosemide—Dermatitis—Rivastigmine—Alzheimer's disease	0.000219	0.00108	CcSEcCtD
Furosemide—Headache—Rivastigmine—Alzheimer's disease	0.000217	0.00107	CcSEcCtD
Furosemide—Nausea—Memantine—Alzheimer's disease	0.000211	0.00104	CcSEcCtD
Furosemide—Nausea—Rivastigmine—Alzheimer's disease	0.000206	0.00102	CcSEcCtD
Furosemide—ALB—Selenium Micronutrient Network—PTGS2—Alzheimer's disease	3.27e-05	0.000263	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS1—Alzheimer's disease	3.24e-05	0.000262	CbGpPWpGaD
Furosemide—CA2—Metabolism—ENO1—Alzheimer's disease	3.24e-05	0.000262	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP2D6—Alzheimer's disease	3.18e-05	0.000256	CbGpPWpGaD
Furosemide—PGD—Disease—CALM1—Alzheimer's disease	3.17e-05	0.000256	CbGpPWpGaD
Furosemide—PGD—Disease—APOE—Alzheimer's disease	3.16e-05	0.000255	CbGpPWpGaD
Furosemide—PGD—Metabolism—LPL—Alzheimer's disease	3.16e-05	0.000255	CbGpPWpGaD
Furosemide—CA4—Metabolism—BCHE—Alzheimer's disease	3.15e-05	0.000254	CbGpPWpGaD
Furosemide—PGD—Disease—CAV1—Alzheimer's disease	3.13e-05	0.000252	CbGpPWpGaD
Furosemide—CA1—Metabolism—ENO1—Alzheimer's disease	3.11e-05	0.000251	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS1—Alzheimer's disease	3.11e-05	0.000251	CbGpPWpGaD
Furosemide—CA12—Metabolism—PPARGC1A—Alzheimer's disease	3.11e-05	0.000251	CbGpPWpGaD
Furosemide—CA12—Metabolism—HMOX1—Alzheimer's disease	3.1e-05	0.00025	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SOD1—Alzheimer's disease	3.09e-05	0.000249	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	3.06e-05	0.000247	CbGpPWpGaD
Furosemide—CA7—Metabolism—LPL—Alzheimer's disease	3.06e-05	0.000246	CbGpPWpGaD
Furosemide—CA5B—Metabolism—LPL—Alzheimer's disease	3.06e-05	0.000246	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP2D6—Alzheimer's disease	3.05e-05	0.000246	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL1B—Alzheimer's disease	3.04e-05	0.000245	CbGpPWpGaD
Furosemide—CA14—Metabolism—MTHFR—Alzheimer's disease	3.03e-05	0.000244	CbGpPWpGaD
Furosemide—CA2—Metabolism—BCHE—Alzheimer's disease	3.02e-05	0.000243	CbGpPWpGaD
Furosemide—CA4—Metabolism—PLCB1—Alzheimer's disease	2.97e-05	0.000239	CbGpPWpGaD
Furosemide—CA6—Metabolism—MTHFR—Alzheimer's disease	2.95e-05	0.000238	CbGpPWpGaD
Furosemide—CA5A—Metabolism—MTHFR—Alzheimer's disease	2.95e-05	0.000238	CbGpPWpGaD
Furosemide—PGD—Disease—NOS2—Alzheimer's disease	2.95e-05	0.000237	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IGF2—Alzheimer's disease	2.94e-05	0.000237	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—TGFB1—Alzheimer's disease	2.94e-05	0.000237	CbGpPWpGaD
Furosemide—CA9—Metabolism—ACHE—Alzheimer's disease	2.92e-05	0.000235	CbGpPWpGaD
Furosemide—PGD—Disease—NOTCH1—Alzheimer's disease	2.92e-05	0.000235	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CLU—Alzheimer's disease	2.9e-05	0.000233	CbGpPWpGaD
Furosemide—CA1—Metabolism—BCHE—Alzheimer's disease	2.89e-05	0.000233	CbGpPWpGaD
Furosemide—CA9—Metabolism—INPP5D—Alzheimer's disease	2.89e-05	0.000233	CbGpPWpGaD
Furosemide—CA4—Metabolism—ABCA1—Alzheimer's disease	2.88e-05	0.000232	CbGpPWpGaD
Furosemide—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—Alzheimer's disease	2.86e-05	0.00023	CbGpPWpGaD
Furosemide—CA2—Metabolism—PLCB1—Alzheimer's disease	2.85e-05	0.000229	CbGpPWpGaD
Furosemide—PGD—Metabolism—MTHFR—Alzheimer's disease	2.84e-05	0.000229	CbGpPWpGaD
Furosemide—CA12—Metabolism—LPL—Alzheimer's disease	2.83e-05	0.000228	CbGpPWpGaD
Furosemide—ALB—Metabolism—DHCR24—Alzheimer's disease	2.83e-05	0.000228	CbGpPWpGaD
Furosemide—CA14—Metabolism—CALM1—Alzheimer's disease	2.83e-05	0.000228	CbGpPWpGaD
Furosemide—CA14—Metabolism—APOE—Alzheimer's disease	2.82e-05	0.000227	CbGpPWpGaD
Furosemide—CA14—Metabolism—CAV1—Alzheimer's disease	2.79e-05	0.000225	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—VEGFA—Alzheimer's disease	2.78e-05	0.000224	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TNF—Alzheimer's disease	2.78e-05	0.000224	CbGpPWpGaD
Furosemide—CA2—Metabolism—ABCA1—Alzheimer's disease	2.76e-05	0.000222	CbGpPWpGaD
Furosemide—CA6—Metabolism—CALM1—Alzheimer's disease	2.75e-05	0.000222	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CALM1—Alzheimer's disease	2.75e-05	0.000222	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IL6—Alzheimer's disease	2.75e-05	0.000222	CbGpPWpGaD
Furosemide—CA7—Metabolism—MTHFR—Alzheimer's disease	2.75e-05	0.000222	CbGpPWpGaD
Furosemide—CA5B—Metabolism—MTHFR—Alzheimer's disease	2.75e-05	0.000222	CbGpPWpGaD
Furosemide—CA6—Metabolism—APOE—Alzheimer's disease	2.74e-05	0.000221	CbGpPWpGaD
Furosemide—CA5A—Metabolism—APOE—Alzheimer's disease	2.74e-05	0.000221	CbGpPWpGaD
Furosemide—PGD—Disease—GSK3B—Alzheimer's disease	2.74e-05	0.000221	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS1—Alzheimer's disease	2.74e-05	0.00022	CbGpPWpGaD
Furosemide—CA9—Metabolism—ENO1—Alzheimer's disease	2.74e-05	0.00022	CbGpPWpGaD
Furosemide—CA1—Metabolism—PLCB1—Alzheimer's disease	2.73e-05	0.00022	CbGpPWpGaD
Furosemide—CA6—Metabolism—CAV1—Alzheimer's disease	2.72e-05	0.000219	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CAV1—Alzheimer's disease	2.72e-05	0.000219	CbGpPWpGaD
Furosemide—PGD—Disease—CREB1—Alzheimer's disease	2.72e-05	0.000219	CbGpPWpGaD
Furosemide—PGD—Disease—INS—Alzheimer's disease	2.7e-05	0.000218	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP2D6—Alzheimer's disease	2.68e-05	0.000216	CbGpPWpGaD
Furosemide—PGD—Metabolism—CALM1—Alzheimer's disease	2.66e-05	0.000214	CbGpPWpGaD
Furosemide—PGD—Metabolism—APOE—Alzheimer's disease	2.65e-05	0.000213	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—PRKCG—Alzheimer's disease	2.65e-05	0.000213	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—Alzheimer's disease	2.65e-05	0.000213	CbGpPWpGaD
Furosemide—CA1—Metabolism—ABCA1—Alzheimer's disease	2.65e-05	0.000213	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.64e-05	0.000212	CbGpPWpGaD
Furosemide—PGD—Metabolism—CAV1—Alzheimer's disease	2.62e-05	0.000211	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—TP53—Alzheimer's disease	2.59e-05	0.000209	CbGpPWpGaD
Furosemide—ALB—Hemostasis—A2M—Alzheimer's disease	2.58e-05	0.000208	CbGpPWpGaD
Furosemide—CA7—Metabolism—CALM1—Alzheimer's disease	2.57e-05	0.000207	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CALM1—Alzheimer's disease	2.57e-05	0.000207	CbGpPWpGaD
Furosemide—CA7—Metabolism—APOE—Alzheimer's disease	2.56e-05	0.000207	CbGpPWpGaD
Furosemide—CA5B—Metabolism—APOE—Alzheimer's disease	2.56e-05	0.000207	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.56e-05	0.000206	CbGpPWpGaD
Furosemide—CA12—Metabolism—MTHFR—Alzheimer's disease	2.55e-05	0.000205	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—TGFB1—Alzheimer's disease	2.55e-05	0.000205	CbGpPWpGaD
Furosemide—CA9—Metabolism—BCHE—Alzheimer's disease	2.54e-05	0.000205	CbGpPWpGaD
Furosemide—CA7—Metabolism—CAV1—Alzheimer's disease	2.54e-05	0.000205	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CAV1—Alzheimer's disease	2.54e-05	0.000205	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARGC1A—Alzheimer's disease	2.48e-05	0.0002	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.48e-05	0.0002	CbGpPWpGaD
Furosemide—CA4—Metabolism—HMOX1—Alzheimer's disease	2.47e-05	0.000199	CbGpPWpGaD
Furosemide—CA14—Metabolism—PPARG—Alzheimer's disease	2.45e-05	0.000198	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TP53—Alzheimer's disease	2.45e-05	0.000197	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—Alzheimer's disease	2.43e-05	0.000196	CbGpPWpGaD
Furosemide—CA14—Metabolism—INS—Alzheimer's disease	2.41e-05	0.000194	CbGpPWpGaD
Furosemide—ALB—Metabolism—CA4—Alzheimer's disease	2.4e-05	0.000194	CbGpPWpGaD
Furosemide—CA9—Metabolism—PLCB1—Alzheimer's disease	2.4e-05	0.000193	CbGpPWpGaD
Furosemide—CA6—Metabolism—PPARG—Alzheimer's disease	2.39e-05	0.000193	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PPARG—Alzheimer's disease	2.39e-05	0.000193	CbGpPWpGaD
Furosemide—CA12—Metabolism—CALM1—Alzheimer's disease	2.38e-05	0.000192	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARGC1A—Alzheimer's disease	2.38e-05	0.000192	CbGpPWpGaD
Furosemide—CA12—Metabolism—APOE—Alzheimer's disease	2.37e-05	0.000191	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—IL6—Alzheimer's disease	2.37e-05	0.000191	CbGpPWpGaD
Furosemide—PGD—Disease—NOS3—Alzheimer's disease	2.37e-05	0.000191	CbGpPWpGaD
Furosemide—CA2—Metabolism—HMOX1—Alzheimer's disease	2.37e-05	0.000191	CbGpPWpGaD
Furosemide—CA12—Metabolism—CAV1—Alzheimer's disease	2.35e-05	0.00019	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.35e-05	0.000189	CbGpPWpGaD
Furosemide—CA6—Metabolism—INS—Alzheimer's disease	2.34e-05	0.000189	CbGpPWpGaD
Furosemide—CA5A—Metabolism—INS—Alzheimer's disease	2.34e-05	0.000189	CbGpPWpGaD
Furosemide—CA9—Metabolism—ABCA1—Alzheimer's disease	2.33e-05	0.000187	CbGpPWpGaD
Furosemide—PGD—Metabolism—PPARG—Alzheimer's disease	2.31e-05	0.000186	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—CALM1—Alzheimer's disease	2.29e-05	0.000185	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARGC1A—Alzheimer's disease	2.28e-05	0.000184	CbGpPWpGaD
Furosemide—CA1—Metabolism—HMOX1—Alzheimer's disease	2.27e-05	0.000183	CbGpPWpGaD
Furosemide—PGD—Metabolism—INS—Alzheimer's disease	2.26e-05	0.000182	CbGpPWpGaD
Furosemide—ALB—Metabolism—GAPDHS—Alzheimer's disease	2.26e-05	0.000182	CbGpPWpGaD
Furosemide—CA4—Metabolism—LPL—Alzheimer's disease	2.26e-05	0.000182	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL6—Alzheimer's disease	2.24e-05	0.000181	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—CP—Alzheimer's disease	2.23e-05	0.00018	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PPARG—Alzheimer's disease	2.23e-05	0.00018	CbGpPWpGaD
Furosemide—CA7—Metabolism—PPARG—Alzheimer's disease	2.23e-05	0.00018	CbGpPWpGaD
Furosemide—ALB—Hemostasis—INPP5D—Alzheimer's disease	2.22e-05	0.000179	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—TNF—Alzheimer's disease	2.21e-05	0.000178	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TF—Alzheimer's disease	2.19e-05	0.000177	CbGpPWpGaD
Furosemide—CA5B—Metabolism—INS—Alzheimer's disease	2.19e-05	0.000176	CbGpPWpGaD
Furosemide—CA7—Metabolism—INS—Alzheimer's disease	2.19e-05	0.000176	CbGpPWpGaD
Furosemide—PGD—Disease—PTGS2—Alzheimer's disease	2.17e-05	0.000175	CbGpPWpGaD
Furosemide—CA2—Metabolism—LPL—Alzheimer's disease	2.17e-05	0.000174	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—F2—Alzheimer's disease	2.15e-05	0.000173	CbGpPWpGaD
Furosemide—ALB—Metabolism—ATP5A1—Alzheimer's disease	2.14e-05	0.000173	CbGpPWpGaD
Furosemide—CA14—Metabolism—NOS3—Alzheimer's disease	2.11e-05	0.00017	CbGpPWpGaD
Furosemide—CA1—Metabolism—LPL—Alzheimer's disease	2.08e-05	0.000167	CbGpPWpGaD
Furosemide—CA12—Metabolism—PPARG—Alzheimer's disease	2.07e-05	0.000167	CbGpPWpGaD
Furosemide—CA6—Metabolism—NOS3—Alzheimer's disease	2.06e-05	0.000166	CbGpPWpGaD
Furosemide—CA5A—Metabolism—NOS3—Alzheimer's disease	2.06e-05	0.000166	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLD3—Alzheimer's disease	2.04e-05	0.000165	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.04e-05	0.000165	CbGpPWpGaD
Furosemide—CA4—Metabolism—MTHFR—Alzheimer's disease	2.03e-05	0.000164	CbGpPWpGaD
Furosemide—CA12—Metabolism—INS—Alzheimer's disease	2.03e-05	0.000163	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.02e-05	0.000163	CbGpPWpGaD
Furosemide—ALB—Hemostasis—GAB2—Alzheimer's disease	2.01e-05	0.000162	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARGC1A—Alzheimer's disease	2e-05	0.000162	CbGpPWpGaD
Furosemide—CA9—Metabolism—HMOX1—Alzheimer's disease	2e-05	0.000161	CbGpPWpGaD
Furosemide—PGD—Metabolism—NOS3—Alzheimer's disease	1.98e-05	0.00016	CbGpPWpGaD
Furosemide—ALB—Metabolism—HSD17B10—Alzheimer's disease	1.96e-05	0.000158	CbGpPWpGaD
Furosemide—ALB—Hemostasis—APP—Alzheimer's disease	1.96e-05	0.000158	CbGpPWpGaD
Furosemide—CA2—Metabolism—MTHFR—Alzheimer's disease	1.95e-05	0.000157	CbGpPWpGaD
Furosemide—CA14—Metabolism—PTGS2—Alzheimer's disease	1.93e-05	0.000156	CbGpPWpGaD
Furosemide—CA7—Metabolism—NOS3—Alzheimer's disease	1.92e-05	0.000155	CbGpPWpGaD
Furosemide—CA5B—Metabolism—NOS3—Alzheimer's disease	1.92e-05	0.000155	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.92e-05	0.000154	CbGpPWpGaD
Furosemide—CA4—Metabolism—CALM1—Alzheimer's disease	1.9e-05	0.000153	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.9e-05	0.000153	CbGpPWpGaD
Furosemide—CA4—Metabolism—APOE—Alzheimer's disease	1.89e-05	0.000153	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP46A1—Alzheimer's disease	1.89e-05	0.000152	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—IGF1—Alzheimer's disease	1.89e-05	0.000152	CbGpPWpGaD
Furosemide—CA5A—Metabolism—PTGS2—Alzheimer's disease	1.88e-05	0.000152	CbGpPWpGaD
Furosemide—CA6—Metabolism—PTGS2—Alzheimer's disease	1.88e-05	0.000152	CbGpPWpGaD
Furosemide—CA4—Metabolism—CAV1—Alzheimer's disease	1.88e-05	0.000151	CbGpPWpGaD
Furosemide—CA1—Metabolism—MTHFR—Alzheimer's disease	1.87e-05	0.000151	CbGpPWpGaD
Furosemide—CA9—Metabolism—LPL—Alzheimer's disease	1.82e-05	0.000147	CbGpPWpGaD
Furosemide—ALB—Metabolism—ND1—Alzheimer's disease	1.82e-05	0.000147	CbGpPWpGaD
Furosemide—CA2—Metabolism—CALM1—Alzheimer's disease	1.82e-05	0.000147	CbGpPWpGaD
Furosemide—CA2—Metabolism—APOE—Alzheimer's disease	1.81e-05	0.000146	CbGpPWpGaD
Furosemide—PGD—Metabolism—PTGS2—Alzheimer's disease	1.81e-05	0.000146	CbGpPWpGaD
Furosemide—CA2—Metabolism—CAV1—Alzheimer's disease	1.8e-05	0.000145	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.78e-05	0.000143	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—Alzheimer's disease	1.78e-05	0.000143	CbGpPWpGaD
Furosemide—CA12—Metabolism—NOS3—Alzheimer's disease	1.78e-05	0.000143	CbGpPWpGaD
Furosemide—CA5B—Metabolism—PTGS2—Alzheimer's disease	1.76e-05	0.000141	CbGpPWpGaD
Furosemide—CA7—Metabolism—PTGS2—Alzheimer's disease	1.76e-05	0.000141	CbGpPWpGaD
Furosemide—CA1—Metabolism—CALM1—Alzheimer's disease	1.75e-05	0.000141	CbGpPWpGaD
Furosemide—CA1—Metabolism—APOE—Alzheimer's disease	1.74e-05	0.00014	CbGpPWpGaD
Furosemide—CA1—Metabolism—CAV1—Alzheimer's disease	1.72e-05	0.000139	CbGpPWpGaD
Furosemide—CA4—Metabolism—PPARG—Alzheimer's disease	1.65e-05	0.000133	CbGpPWpGaD
Furosemide—CA9—Metabolism—MTHFR—Alzheimer's disease	1.64e-05	0.000132	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.63e-05	0.000131	CbGpPWpGaD
Furosemide—CA12—Metabolism—PTGS2—Alzheimer's disease	1.63e-05	0.000131	CbGpPWpGaD
Furosemide—CA4—Metabolism—INS—Alzheimer's disease	1.62e-05	0.00013	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SOD1—Alzheimer's disease	1.59e-05	0.000128	CbGpPWpGaD
Furosemide—CA2—Metabolism—PPARG—Alzheimer's disease	1.58e-05	0.000127	CbGpPWpGaD
Furosemide—PGD—Disease—TGFB1—Alzheimer's disease	1.57e-05	0.000126	CbGpPWpGaD
Furosemide—CA2—Metabolism—INS—Alzheimer's disease	1.55e-05	0.000125	CbGpPWpGaD
Furosemide—CA9—Metabolism—CALM1—Alzheimer's disease	1.54e-05	0.000124	CbGpPWpGaD
Furosemide—CA9—Metabolism—APOE—Alzheimer's disease	1.53e-05	0.000123	CbGpPWpGaD
Furosemide—CA1—Metabolism—PPARG—Alzheimer's disease	1.52e-05	0.000122	CbGpPWpGaD
Furosemide—CA9—Metabolism—CAV1—Alzheimer's disease	1.52e-05	0.000122	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF2—Alzheimer's disease	1.51e-05	0.000122	CbGpPWpGaD
Furosemide—CA1—Metabolism—INS—Alzheimer's disease	1.49e-05	0.00012	CbGpPWpGaD
Furosemide—CA4—Metabolism—NOS3—Alzheimer's disease	1.42e-05	0.000114	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.4e-05	0.000113	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PRKCG—Alzheimer's disease	1.36e-05	0.00011	CbGpPWpGaD
Furosemide—CA2—Metabolism—NOS3—Alzheimer's disease	1.36e-05	0.00011	CbGpPWpGaD
Furosemide—CA9—Metabolism—PPARG—Alzheimer's disease	1.33e-05	0.000107	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.33e-05	0.000107	CbGpPWpGaD
Furosemide—CA9—Metabolism—INS—Alzheimer's disease	1.31e-05	0.000105	CbGpPWpGaD
Furosemide—CA1—Metabolism—NOS3—Alzheimer's disease	1.3e-05	0.000105	CbGpPWpGaD
Furosemide—CA4—Metabolism—PTGS2—Alzheimer's disease	1.3e-05	0.000105	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.28e-05	0.000103	CbGpPWpGaD
Furosemide—CA2—Metabolism—PTGS2—Alzheimer's disease	1.24e-05	0.0001	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—Alzheimer's disease	1.23e-05	9.93e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAU—Alzheimer's disease	1.19e-05	9.62e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—PTGS2—Alzheimer's disease	1.19e-05	9.61e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CALM1—Alzheimer's disease	1.18e-05	9.52e-05	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—Alzheimer's disease	1.18e-05	9.51e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CHAT—Alzheimer's disease	1.17e-05	9.46e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—TPI1—Alzheimer's disease	1.17e-05	9.46e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—CAV1—Alzheimer's disease	1.17e-05	9.39e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—NOS3—Alzheimer's disease	1.15e-05	9.24e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TGFB1—Alzheimer's disease	1.13e-05	9.11e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—MAOB—Alzheimer's disease	1.13e-05	9.07e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—F2—Alzheimer's disease	1.11e-05	8.94e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS2—Alzheimer's disease	1.1e-05	8.84e-05	CbGpPWpGaD
Furosemide—PGD—Disease—AKT1—Alzheimer's disease	1.09e-05	8.78e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—GAPDH—Alzheimer's disease	1.08e-05	8.73e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.07e-05	8.63e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.06e-05	8.55e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—PTGS2—Alzheimer's disease	1.05e-05	8.45e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—A2M—Alzheimer's disease	1.05e-05	8.43e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—IGF1—Alzheimer's disease	9.72e-06	7.84e-05	CbGpPWpGaD
Furosemide—CA14—Metabolism—AKT1—Alzheimer's disease	9.7e-06	7.82e-05	CbGpPWpGaD
Furosemide—CA6—Metabolism—AKT1—Alzheimer's disease	9.45e-06	7.62e-05	CbGpPWpGaD
Furosemide—CA5A—Metabolism—AKT1—Alzheimer's disease	9.45e-06	7.62e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.33e-06	7.52e-05	CbGpPWpGaD
Furosemide—PGD—Metabolism—AKT1—Alzheimer's disease	9.12e-06	7.35e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ACHE—Alzheimer's disease	9.1e-06	7.34e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—INPP5D—Alzheimer's disease	9e-06	7.25e-05	CbGpPWpGaD
Furosemide—CA5B—Metabolism—AKT1—Alzheimer's disease	8.82e-06	7.11e-05	CbGpPWpGaD
Furosemide—CA7—Metabolism—AKT1—Alzheimer's disease	8.82e-06	7.11e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS3—Alzheimer's disease	8.81e-06	7.1e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS1—Alzheimer's disease	8.53e-06	6.87e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ENO1—Alzheimer's disease	8.53e-06	6.87e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP2D6—Alzheimer's disease	8.36e-06	6.74e-05	CbGpPWpGaD
Furosemide—CA12—Metabolism—AKT1—Alzheimer's disease	8.17e-06	6.59e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—BCHE—Alzheimer's disease	7.93e-06	6.39e-05	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—AKT1—Alzheimer's disease	7.86e-06	6.33e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PLCB1—Alzheimer's disease	7.48e-06	6.03e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.34e-06	5.91e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—ABCA1—Alzheimer's disease	7.25e-06	5.84e-05	CbGpPWpGaD
Furosemide—CA4—Metabolism—AKT1—Alzheimer's disease	6.52e-06	5.25e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—Alzheimer's disease	6.35e-06	5.12e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARGC1A—Alzheimer's disease	6.25e-06	5.04e-05	CbGpPWpGaD
Furosemide—CA2—Metabolism—AKT1—Alzheimer's disease	6.25e-06	5.04e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMOX1—Alzheimer's disease	6.22e-06	5.01e-05	CbGpPWpGaD
Furosemide—CA1—Metabolism—AKT1—Alzheimer's disease	5.99e-06	4.83e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TGFB1—Alzheimer's disease	5.83e-06	4.7e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—LPL—Alzheimer's disease	5.69e-06	4.59e-05	CbGpPWpGaD
Furosemide—CA9—Metabolism—AKT1—Alzheimer's disease	5.27e-06	4.25e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—MTHFR—Alzheimer's disease	5.12e-06	4.13e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TP53—Alzheimer's disease	4.8e-06	3.87e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CALM1—Alzheimer's disease	4.79e-06	3.86e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—APOE—Alzheimer's disease	4.77e-06	3.84e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—CAV1—Alzheimer's disease	4.73e-06	3.81e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PPARG—Alzheimer's disease	4.15e-06	3.35e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—INS—Alzheimer's disease	4.08e-06	3.28e-05	CbGpPWpGaD
Furosemide—ALB—Hemostasis—AKT1—Alzheimer's disease	4.05e-06	3.27e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—NOS3—Alzheimer's disease	3.57e-06	2.88e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—PTGS2—Alzheimer's disease	3.27e-06	2.63e-05	CbGpPWpGaD
Furosemide—ALB—Metabolism—AKT1—Alzheimer's disease	1.64e-06	1.32e-05	CbGpPWpGaD
